A 2022 analysis of FDA adverse-event reports, published in Frontiers in Endocrinology , identified 2,670 reported cases of acute kidney injury linked to GLP-1 medicines over an 18-year span
However, multiple treatment sessions are necessary to achieve optimal results, and there may be some redness, swelling, or temporary darkening in the treated areas, which will subside within a few hours after the treatment
Laboratory storage and reconstituted stability Lyophilized KLOW should be stored frozen at 20 C or below, protected from light and moisture
Shindo Y, Witt E, Han D, Epstein W, Packer L
As such, new treatment options are required, and current data that will be reviewed make the glucagon like peptide-1 receptor antagonist (GLP-1 RA) class a potential novel asthma therapy
Other serious side effects of the medication include the possibility of lowered levels of blood glucose